Abstract
A patient with metastatic breast cancer treated with epirubicin (Pharmorubicin) developed a severe urticarial reaction which progressed to ulceration following possible sensitisation to the drug by preceding extravasation.
MeSH terms
-
Bone Neoplasms / secondary
-
Breast Neoplasms / complications
-
Drug Hypersensitivity*
-
Epirubicin / adverse effects
-
Epirubicin / therapeutic use*
-
Extravasation of Diagnostic and Therapeutic Materials
-
Female
-
Humans
-
Middle Aged